The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.
Thanks for your support as we work to rapidly get this testing available to you. You can find the FAQ document here: CTS COVID-19 Questions and Answers
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...